Clinical trials
Arthritis, Psoriatic trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
106 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 7 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 7 |
| 2016 | 7 |
| 2017 | 7 |
| 2018 | 4 |
| 2019 | 11 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 72 |
| Recruiting | 13 |
| Active, not recruiting | 12 |
| Unknown status | 5 |
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 13 |
| Janssen Research & Development, LLC | 12 |
| UCB Biopharma SRL | 12 |
| AbbVie | 9 |
| Pfizer | 9 |
| Amgen | 8 |
| Bristol-Myers Squibb | 4 |
| Takeda | 4 |
| University of Erlangen-Nürnberg Medical School | 4 |
| MoonLake Immunotherapeutics AG | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Psoriatic | 106 |
| Psoriasis | 18 |
| Arthritis | 14 |
| Arthritis, Rheumatoid | 7 |
| Axial Spondyloarthritis | 6 |
| Skin Diseases | 5 |
| Crohn Disease | 4 |
| Colitis, Ulcerative | 3 |
| Inflammation | 3 |
| Joint Diseases | 3 |
Trials
Showing 76 to 100 of 106. Each trial links to its page on Pharma Observatory.
6 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.